From duvet covers to tracksuits: Dunkin' bringing back limited-edition merch
The merch drop coincides with Dunkin' Iced Coffee Day on June 18, an annual fundraiser for the Dunkin' Joy in Childhood Foundation, a non-profit organization that "provides grants to hundreds of nonprofits each year making a difference in the lives of kids battling hunger or illness across the country."
One dollar from every iced coffee and cold brew sold at participating Dunkin' locations nationwide will be donated to the foundation, which is powered by powered by Dunkin' and franchisees, partners, employees and guests.
"One hundred percent of the donated funds raised on Dunkin' Iced Coffee Day will go back to local communities, supporting health and hunger relief organizations that share the Foundation's commitment to delivering joy to kids when and where it's needed most," Dunkin said in a June 12 news release.
Dunkin' says 100% of proceeds from sales on ShopDunkin.com will also support the foundation while supplies last.
All sorts of Dunkin' merch, including clothing and a donut pool, will return to Dunkin's online shop on June 18, while supplies last.
"Dunkin' is bringing back previous launches and past sold-out merchandise," Dunkin' said in the news release. "From the brand's first-ever wedding merch collection to Dunkin' duvet covers, fan-favorite pieces are making a comeback on June 18."
Customers get a "second chance to shop while supporting a joyful cause."
The price range for the products was not immediately available.
This article originally appeared on USA TODAY: Dunkin' bringing back sold-out merch for one day only
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
33 minutes ago
- Business Upturn
LIS Technologies Inc. Appoints Distinguished Nuclear Expert Lloyd Jollay as its UF6 Systems Manager
Lloyd Jollay's addition continues LIS Technologies' initiative to build a management team consisting of veteran nuclear industry specialists and leaders. Oak Ridge, Tennessee, July 16, 2025 (GLOBE NEWSWIRE) — LIS Technologies Inc. ('LIST' or 'the Company'), a proprietary developer of advanced laser technology and the only USA-origin and patented laser uranium enrichment company, today announced that Lloyd Jollay, a seasoned nuclear engineering professional with over 30 years of experience in nuclear safety, materials management, and advanced fuel cycle operations, has been appointed as it UF 6 Systems Manager. 'LIST's patented CRISLA technology has the potential to support the revitalization and growth of the nation's nuclear-fuel supply chain,' said Lloyd Jollay, UF 6 Systems Manager of LIS Technologies Inc. 'The Company has taken a leading role in this industry's innovation and decisive steps to rebirth, demonstrate and subsequently commercialize its technology. I look forward to putting my industry experience to work in support of this mission.' Former Vice President of Isotopes and Nuclear Fuel Cycle at Boston Government Services, Lloyd Jollay led the development of nuclear safety programs and provided licensing support for emerging advanced reactor and isotope production initiatives. His extensive background includes managing criticality safety programs, supporting the peaceful use and transport of uranium materials, and advising on nuclear nonproliferation strategies within the DOE and NNSA complex. Figure 1 – LIS Technologies Inc. Appoints Seasoned Nuclear Engineering Professional Lloyd Jollay as its UF 6 Systems Manager. In his prior roles, Mr. Jollay held multiple leadership positions at the Y-12 National Security Complex in Oak Ridge, Tennessee. His work included directing nuclear material applications, overseeing high-enriched uranium (HEU) supply and return efforts, and managing multimillion-dollar budgets supporting domestic and international nuclear nonproliferation. He also led criticality safety teams, supporting safe nuclear operations through rigorous documentation, evaluations, and compliance with regulatory bodies including NPO, NNSA, and the DNFSB. Mr. Jollay holds an MBA and a B.S. in Engineering Physics from the University of Tennessee, Knoxville, where he also completed coursework toward an M.S. in Nuclear Engineering. He is a certified Six Sigma Black Belt, has completed advanced training in SCALE and MCNP, and maintains active membership in the American Nuclear Society and the Institute of Nuclear Materials Management. 'I'm pleased to welcome Lloyd to LIS Technologies,' said Jay Yu, Executive Chairman and President of LIS Technologies Inc. 'Bringing in seasoned leaders is essential as we scale, and Lloyd's depth of experience in the nuclear sector will strengthen our management team at a critical juncture. His track record and commitment to the industry will be instrumental as we work to position LIST at the forefront of America's nuclear fuel supply chain revitalization.' 'Lloyd's addition comes at a pivotal moment as we move toward the next phase of our technology's development,' said Christo Liebenberg, CEO and Co-Founder of LIS Technologies Inc. 'With decades of experience in nuclear operations and non-proliferation, and his many connections with nuclear entities in the Oak Ridge area and nationwide, he brings along fresh perspective to help guide our work responsibly. Lloyd has consistently championed innovative solutions throughout his career, and I am pleased to have him on the team.' About LIS Technologies Inc. LIS Technologies Inc. (LIST) is a USA based, proprietary developer of a patented advanced laser technology, making use of infrared lasers to selectively excite the molecules of desired isotopes to separate them from other isotopes. The Laser Isotope Separation Technology (L.I.S.T) has a huge range of applications, including being the only USA-origin (and patented) laser uranium enrichment company, and several major advantages over traditional methods such as gas diffusion, centrifuges, and prior art laser enrichment. The LIST proprietary laser-based process is more energy-efficient and has the potential to be deployed with highly competitive capital and operational costs. L.I.S.T is optimized for LEU (Low Enriched Uranium) for existing civilian nuclear power plants, High-Assay LEU (HALEU) for the next generation of Small Modular Reactors (SMR) and Microreactors, the production of stable isotopes for medical and scientific research, and applications in quantum computing manufacturing for semiconductor technologies. The Company employs a world class nuclear technical team working alongside leading nuclear entrepreneurs and industry professionals, possessing strong relationships with government and private nuclear industries. In Dec 2024, LIS Technologies Inc. was selected as one of six domestic companies to participate in the Low-Enriched Uranium (LEU) Enrichment Acquisition Program. This initiative allocates up to $3.4 billion overall, with contracts lasting for up to 10 years. Each awardee is slated to receive a minimum contract of $2 million. For more information please visit: For further information, please contact: Email: [email protected]Telephone: 800-388-5492Follow us on X Platform Follow us on LinkedIn
Yahoo
2 hours ago
- Yahoo
Bank of America Reports Second Quarter 2025 Financial Results
CHARLOTTE, N.C., July 16, 2025 /PRNewswire/ -- Bank of America reported its second quarter 2025 financial results today. The news release, supplemental filing and investor presentation can be accessed at Bank of America's Investor Relations website at A Form 8-K containing Bank of America's financial results is also available at the U.S. Securities and Exchange Commission's website at Investor Conference Call informationChief Executive Officer Brian Moynihan and Chief Financial Officer Alastair Borthwick will discuss the financial results in an investor conference call at 8 a.m. ET today. For a listen-only connection to the conference call, dial 1.877.200.4456 (U.S.) or 1.785.424.1732 (international), and the conference ID is 79795. Please dial in 10 minutes prior to the start of the call. Investors can listen to live audio of the conference call and view the presentation slides by visiting the "Events and Presentations" section of the company's Investor Relations website. Replay information for Investor Conference CallInvestors can access replays of the investor conference call by visiting the Investor Relations website or by calling 1.800.934.4850 (U.S.) or 1.402.220.1178 (international) from noon on July 16 through 11:59 p.m. ET on July 25. Bank of AmericaBank of America is one of the world's leading financial institutions, serving individual consumers, small and middle-market businesses and large corporations with a full range of banking, investing, asset management and other financial and risk management products and services. The company provides unmatched convenience in the United States, serving approximately 69 million consumer and small business clients with approximately 3,700 retail financial centers, approximately 15,000 ATMs (automated teller machines) and award-winning digital banking with approximately 59 million verified digital users. Bank of America is a global leader in wealth management, corporate and investment banking and trading across a broad range of asset classes, serving corporations, governments, institutions and individuals around the world. Bank of America offers industry-leading support to approximately 4 million small business households through a suite of innovative, easy-to-use online products and services. The company serves clients through operations across the United States, its territories and more than 35 countries. Bank of America Corporation stock is listed on the New York Stock Exchange (NYSE: BAC). For more Bank of America news, including dividend announcements and other important information, visit the Bank of America newsroom and register for news email alerts. Investors May Contact: Lee McEntire, Bank of AmericaPhone: Jonathan Blum, Bank of America (Fixed Income)Phone: Reporters May Contact: Jocelyn Seidenfeld, Bank of AmericaPhone: View original content to download multimedia: SOURCE Bank of America Corporation Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Many US employers plan to pare health benefits as weight-loss spending soars
By Amina Niasse NEW YORK (Reuters) -More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and specialty drugs squeeze budgets, according to a new survey released by consulting firm Mercer on Wednesday. Among employers with 500 or more workers, 51% said they planned to increase cost-sharing in 2026, including raising deductibles and maximum out-of-pocket costs for workers. That is up from 45% of large employers who said they would increase cost-sharing for 2025. Concern over the cost of GLP-1 weight-loss drugs like Novo Nordisk's Wegovy has surged, with 77% of employers naming them a top issue, the consultancy said. "More clients are saying ... 'I don't know how much longer we can sustain covering these medications'," said Alysha Fluno, a pharmacy innovation leader at Mercer, in an interview. While some employers have covered GLP-1s hoping for long-term health savings, rising prices are forcing a rethink: "Some employers facing big cost increases in 2026 may feel this coverage is out of reach," Fluno said. Greater competition in the weight-loss drug market in coming years will give pharmacy benefit managers more negotiating power with drugmakers and drive meaningful cost reductions, said Fluno. Novo's Wegovy and Eli Lilly's Zepbound are listed at $1086 and $1059, respectively, but many patients pay less through their health plans. Prescription drug costs jumped 8% last year, according to the survey. Mercer has forecast a 5.8% rise in overall health benefit costs for 2025. Employers are also eyeing alternatives to traditional pharmacy benefit managers (PBMs), according to Mercer. PBMs such as CVS Caremark, Cigna's Express Scripts and UnitedHealthcare's Optum Rx act as middlemen between drug companies and consumers. They negotiate volume discounts and fees with drug manufacturers on behalf of employers and health plans, create lists of medications that are covered by insurance, and reimburse pharmacies for prescriptions. Drugmakers say they take an undisclosed cut of the discounts they receive rather than sharing them with patients and payers. Regulatory scrutiny and calls for transparency are fueling interest in new models and emerging PBMs, with 34% of employers considering a switch. The survey found 40% of employers are considering alternative contracting models for their prescription medicine benefits, such as those that price drugs based on the wholesale price that retail pharmacies pay for them. Regulators have criticized the three largest pharmacy benefit managers for steering patients toward more expensive drugs and inflating prices to generate revenue gains, an accusation that the industry denies. California pension fund CalPERS, the second-largest public purchaser of health benefits in the U.S., announced on Tuesday that Caremark would replace UnitedHealth's Optum Rx as the fund's PBM in 2026. CalPERS said its five-year contract with Caremark requires the PBM to boost transparency and oversight.
